Safety and efficacy of a phase 1 clinical gene therapy trial in patients with advanced heart failure using a rationally designed cardiotropic AAV vector targeting protein phosphatase inhibitor-1
Event:
Heart Failure 2024
Topic:
Pharmacotherapy
Session:
Chronic heart failure - treatment 5